Bitcoin price today: dips below $112k, near 6-wk low despite Fed cut bets
Achilles B. Kintiroglou, the Senior Vice President and General Counsel of AdvanSix Inc . (NYSE:ASIX), recently sold 4,000 shares of the company’s common stock. The sale, executed on April 1, 2025, was conducted at a price of $22.24 per share, amounting to a total transaction value of $88,960. According to InvestingPro data, the stock appears undervalued at current levels, with analysts setting price targets between $35 and $40. Following this sale, Kintiroglou holds 36,363 shares in AdvanSix. The transaction was carried out under a Rule 10b5-1 trading plan, which Kintiroglou adopted on November 12, 2024. The company, with a market capitalization of approximately $599 million, has demonstrated resilience with a healthy current ratio of 1.08 and maintains a dividend yield of 2.85%. For deeper insights into AdvanSix’s financial health and growth prospects, investors can access the comprehensive Pro Research Report available on InvestingPro.
In other recent news, Piper Sandler has adjusted its price target for AdvanSix, lowering it to $35 from $39, while maintaining an Overweight rating on the shares. This revision follows the company’s release of its fourth-quarter and full-year 2024 earnings, alongside new guidance for 2025. AdvanSix has reported a significant year-over-year increase in EBITDA for 2025, attributed to strong sales of ammonium sulfate and acetone. These products are expected to continue driving earnings growth in the future. Other chemical intermediates like nylon and caprolactam are projected to offer modest growth due to subdued economic conditions globally. Despite a slight decrease in earnings projections through 2026, AdvanSix’s adjusted EBITDA is anticipated to reach $223 million in 2025, up from $142 million in 2024. Piper Sandler’s analysis highlights the expected earnings strength in key product areas, contributing to the maintained Overweight rating. Investors are likely to keep a close watch on these developments, given the strategic importance of AdvanSix’s position in the chemical intermediates market.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.